Coffin–Siris syndrome

From Food & Medicine Encyclopedia

Coffin–Siris syndrome
Synonyms Dwarfism-Onychodysplasia, Fifth Digit Syndrome, Mental Retardation with Hypoplastic 5th Fingernails and Toenails, Short Stature-Onychodysplasia
Pronounce
Field Medical genetics, Pediatrics
Symptoms Developmental delay, intellectual disability, coarse facial features, hypotonia, absent or hypoplastic nails on the fifth digits
Complications Delayed motor and language skills, feeding difficulties, respiratory infections, possible seizures
Onset Congenital (present at birth)
Duration Lifelong
Types Multiple subtypes associated with different gene mutations (e.g. ARID1B, SOX11, ARID2)
Causes Genetic mutation (commonly de novo), especially in genes related to the SWI/SNF chromatin remodeling complex
Risks Sporadic (de novo) or inherited in an autosomal dominant pattern
Diagnosis Clinical diagnosis supported by genetic testing
Differential diagnosis Nicolaides–Baraitser syndrome, Brachymorphism-Onychodysplasia-Dysphalangism syndrome
Prevention None known
Treatment Symptomatic and supportive: physical therapy, occupational therapy, speech therapy, special education
Medication As needed for comorbidities (e.g., anticonvulsants for seizures)
Prognosis Varies; many children can live into adulthood with supportive care
Frequency Fewer than 100 cases reported in literature
Deaths Rare; depends on severity and complications


Boy with Coffin–Siris syndrome showing typical features
Illustration of de novo mutations associated with rare genetic disorders

Coffin–Siris syndrome (CSS) is a rare genetic disorder characterized by developmental delay, intellectual disability, hypoplasia or aplasia of the nails on the fifth fingers and toes, and distinctive facial features. First described in 1970 by Grange S. Coffin and Evelyn Siris, the syndrome has since been linked to mutations in multiple genes, most commonly those encoding components of the SWI/SNF chromatin remodeling complex.

Clinical Features[edit]

The syndrome has a broad spectrum of symptoms that can range from mild to severe. Common clinical features include:

Causes[edit]

Coffin–Siris syndrome is most commonly caused by de novo mutations in genes related to chromatin remodeling. These include:

The condition is typically inherited in an autosomal dominant fashion, though most cases are sporadic and arise from a de novo mutation.

Genetics[edit]

All known causative genes are involved in the function of the SWI/SNF chromatin remodeling complex, which regulates gene expression by altering chromatin structure. Disruption of this complex affects multiple developmental pathways, leading to the wide range of observed symptoms.

Diagnosis[edit]

Diagnosis is primarily clinical and based on:

  • Presence of distinctive phenotypic features
  • Developmental and intellectual assessment
  • Absent or underdeveloped fifth digit nails

Confirmation is achieved through molecular genetic testing, typically using whole exome sequencing or targeted gene panels for SWI/SNF complex mutations.

Differential Diagnosis[edit]

Conditions that may mimic Coffin–Siris syndrome and should be considered in the differential include:

Treatment[edit]

There is no cure for Coffin–Siris syndrome. Treatment is symptomatic and supportive:

Prognosis[edit]

The prognosis depends on the severity of symptoms and associated complications. With appropriate therapies and support, many individuals achieve varying degrees of independence. Severe cases with associated anomalies may have a more guarded prognosis.

Epidemiology[edit]

Coffin–Siris syndrome is extremely rare. Fewer than 100 cases have been reported in the medical literature. Due to variable expression and overlap with other syndromes, it may be underdiagnosed.

See also[edit]

External Links[edit]



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.